A.6 ASC 325, Investments — Other
ASC 325-30
Statement of Financial Position
45-1 An
investor shall report its investments that are remeasured at fair
value on the face of the statement of financial position separately
from those accounted for under the investment method. To accomplish
that separate reporting, an investor shall do either of the
following:
- Display separate line items on the statement of financial position for the fair value method and investment method carrying amounts
- Present the aggregate of those fair value method and investment method carrying amounts and parenthetically disclose the amount of those investments accounted for under the fair value method included in the aggregate amount.
Income Statement
45-3 An
investor shall report the investment income from its investments in
life settlement contracts that are remeasured at fair value on the
face of the income statement separately from the investment income
from those accounted for under the investment method. To accomplish
that separate reporting, an investor shall do either of the
following:
- Display separate line items on the income statement for the investment income from the investments in life settlement contracts that are accounted for under the fair value method and investment method
- Present the aggregate of the investment income in life settlement contracts and parenthetically disclose the investment income from those investments accounted for under the fair value method that are included in the aggregate amount.
45-4 An
investor applying the fair value method shall account for premiums
paid and life insurance proceeds received on the same financial
reporting line as the changes in fair value are reported.
50-3 The disclosure requirements in
this Subsection do not eliminate disclosure requirements included in
other Topics, including other disclosure requirements on the use of
fair value.
Fair Value Method
50-7 An
investor shall disclose the method(s) and significant assumptions
used to estimate the fair value of investments in life settlement
contracts, including any mortality assumptions.
50-8 An
investor shall disclose all of the following for life settlement
contracts accounted for under the fair value method based on
remaining life expectancy for each of the first five succeeding
years from the date of the statement of financial position and
thereafter, as well as in the aggregate:
- The number of life settlement contracts
- The carrying value of the life settlement contracts
- The face value (death benefits) of the life insurance policies underlying the contracts.
50-10 An
investor shall disclose both of the following for each reporting
period presented in the income statement:
- The gains or losses recognized during the period on investments sold during the period
- The unrealized gains or losses recognized during the period on investments that are still held at the date of the statement of financial position.